Development, Evaluation, and Initial Findings of New York State Department of Health Community Drug Checking Pilot Programs.
Journal
Journal of public health management and practice : JPHMP
ISSN: 1550-5022
Titre abrégé: J Public Health Manag Pract
Pays: United States
ID NLM: 9505213
Informations de publication
Date de publication:
10 Oct 2024
10 Oct 2024
Historique:
medline:
13
10
2024
pubmed:
13
10
2024
entrez:
10
10
2024
Statut:
aheadofprint
Résumé
The illicit drug landscape in the United States is dynamic, featuring a risky and erratic drug supply. Drug checking programs (DCP) have been successfully implemented and studied extensively in Canada and Europe but are scarce in the United States. Integrating DCP at harm reduction programs provides an opportunity to engage people at the point-of-care and deliver a combination of harm reduction services, access to healthcare services, and linkages to treatment. The New York State Department of Health (NYSDOH) developed and supports operation of 8 pilot community DCP sites throughout the state. The DCP were trained to utilize Fourier-transform infrared spectroscopy (FTIR) technology to deliver real-time results to participants. The NYSDOH community DCP pilot began development in 2022. Partnerships were formed across multiple domains including other DCP, universities, forensic laboratories, syringe service and harm reduction programs, and legal and regulatory offices within the NYSDOH. The first pilot sites began operating in mid-2023 and program expansion is on-going. Evaluation staff were extensively engaged in development and implementation phases. Qualitative evaluation focused on barriers, facilitators, and lessons learned from program staff and technicians. Quantitative evidence was gathered to assess the reach of the DCP and accuracy of results attained by drug checking technicians during their training periods. Drug checking results helped characterize the illicit drug supply. Development and implementation of DCP in NYS was facilitated by strong partnerships across sectors including public health and harm reduction. DCP may involve diverse partners who do not regularly collaborate, and health departments are positioned to build relationships and convene partners for program implementation. Evaluation findings highlight the importance of facilitating on-going training and technical assistance to DCP for quality assurance. The initial successes and lessons learned from the NYSDOH DCP demonstrate state public health departments' ability to successfully deploy this innovative harm reduction strategy.
Identifiants
pubmed: 39387612
doi: 10.1097/PHH.0000000000002061
pii: 00124784-990000000-00348
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors have indicated they have no potential conflicts of interest to disclose.
Références
Ahmad FB CJ, Cisewski JA, Rossen LM, Sutton P Provisional Drug Overdose Death Counts. Centers for Disease Control and Prevention National Center for Health Statistics. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm. Accessed March 27, 2024.
Harper L, Powell J, Pijl EM. An overview of forensic drug testing methods and their suitability for harm reduction point-of-care services. Harm Reduct J. 2017;14(1):52. doi:10.1186/s12954-017-0179-5.
doi: 10.1186/s12954-017-0179-5
Bardwell G, Boyd J, Arredondo J, McNeil R, Kerr T. Trusting the source: the potential role of drug dealers in reducing drug-related harms via drug checking. Drug Alcohol Depend. 2019;198:1-6. doi:10.1016/j.drugalcdep.2019.01.035.
doi: 10.1016/j.drugalcdep.2019.01.035
Brunt T. Drug checking as a harm reduction tool for recreational drug users: opportunities and challenges; 2017. https://www.euda.europa.eu/document-library/drug-checking-pill-testing-harm-reduction-tool-recreational-drug-users-opportunities-and-challenges_en. Accessed July 19, 2024.
Mema SC, Sage C, Xu Y, et al. Drug checking at an electronic dance music festival during the public health overdose emergency in British Columbia. Can J Public Health. 2018;109(5-6):740-744. doi:10.17269/s41997-018-0126-6.
doi: 10.17269/s41997-018-0126-6
DanceSafe. https://dancesafe.org/about-us/. Accessed March 27, 2024.
Karamouzian M, Dohoo C, Forsting S, McNeil R, Kerr T, Lysyshyn M. Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada. Harm Reduct J. 2018;15(1):46. doi:10.1186/s12954-018-0252-8.
doi: 10.1186/s12954-018-0252-8
Laing MK, Ti L, Marmel A, et al. An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: preliminary results from a community drug checking program using point-of-care and confirmatory methods. Int J Drug Policy. 2021;93:103169. doi:10.1016/j.drugpo.2021.103169.
doi: 10.1016/j.drugpo.2021.103169
Mema SC, Sage C, Popoff S, Bridgeman J, Taylor D, Corneil T. Expanding harm reduction to include fentanyl urine testing: results from a pilot in rural British Columbia. Harm Reduct J. 2018;15(1):19. doi:10.1186/s12954-018-0224-z.
doi: 10.1186/s12954-018-0224-z
Tupper KW, McCrae K, Garber I, Lysyshyn M, Wood E. Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting. Drug Alcohol Depend. 2018;190:242-245. doi:10.1016/j.drugalcdep.2018.06.020.
doi: 10.1016/j.drugalcdep.2018.06.020
Bailey K, Abramovitz D, Artamonova I, et al. Drug checking in the fentanyl era: utilization and interest among people who inject drugs in San Diego, California. Int J Drug Policy. 2023;118:104086. doi:10.1016/j.drugpo.2023.104086.
doi: 10.1016/j.drugpo.2023.104086
Maghsoudi N, Tanguay J, Scarfone K, et al. Drug checking services for people who use drugs: a systematic review. Addiction. 2022;117(3):532-544. doi:10.1111/add.15734.
doi: 10.1111/add.15734
Barry CL. Fentanyl and the evolving opioid epidemic: what strategies should policy makers consider? Psychiatr Serv. 2018;69(1):100-103. doi:10.1176/appi.ps.201700235.
doi: 10.1176/appi.ps.201700235
Laing MK, Tupper KW, Fairbairn N. Drug checking as a potential strategic overdose response in the fentanyl era. Int J Drug Policy. 2018;62:59-66. doi:10.1016/j.drugpo.2018.10.001.
doi: 10.1016/j.drugpo.2018.10.001
Betsos A, Valleriani J, Boyd J, Bardwell G, Kerr T, McNeil R. “I couldn’t live with killing one of my friends or anybody”: a rapid ethnographic study of drug sellers’ use of drug checking. Int J Drug Policy. 2021;87:102845. doi:10.1016/j.drugpo.2020.102845.
doi: 10.1016/j.drugpo.2020.102845
Green TC, Olson R, Jarczyk C, et al. Implementation and uptake of the Massachusetts drug supply data stream: a statewide public health-public safety partnership drug checking program. J Public Health Manag Pract. 2022;28(Suppl 6):S347-S354. doi:10.1097/phh.0000000000001581.
doi: 10.1097/phh.0000000000001581
Park JN, Tardif J, Thompson E, Rosen JG, Lira JAS, Green TC. A survey of North American drug checking services operating in 2022. Int J Drug Policy. 2023;121:104206. doi:10.1016/j.drugpo.2023.104206.
doi: 10.1016/j.drugpo.2023.104206
Glick JL, Christensen T, Park JN, McKenzie M, Green TC, Sherman SG. Stakeholder perspectives on implementing fentanyl drug checking: results from a multi-site study. Drug Alcohol Depend. 2019;194:527-532. doi:10.1016/j.drugalcdep.2018.10.017.
doi: 10.1016/j.drugalcdep.2018.10.017
Davis CS, Lieberman AJ, O’Kelley-Bangsberg M. Legality of drug checking equipment in the United States: a systematic legal analysis. Drug Alcohol Depend. 2022;234:109425. doi:10.1016/j.drugalcdep.2022.109425.
doi: 10.1016/j.drugalcdep.2022.109425
Establishes a drug checking services program, Senate Bill S4880C; 2023. https://www.nysenate.gov/legislation/bills/2023/S4880/amendment/C. Accessed July 22, 2024.
Krieger MS, Yedinak JL, Buxton JA, et al. High willingness to use rapid fentanyl test strips among young adults who use drugs. Harm Reduct J. 2018;15(1):7. doi:10.1186/s12954-018-0213-2.
doi: 10.1186/s12954-018-0213-2
Sherman SG, Morales KB, Park JN, McKenzie M, Marshall BDL, Green TC. Acceptability of implementing community-based drug checking services for people who use drugs in three United States cities: Baltimore, Boston and Providence. Int J Drug Policy. 2019;68:46-53. doi:10.1016/j.drugpo.2019.03.003.
doi: 10.1016/j.drugpo.2019.03.003
Crepeault H, Socias ME, Tobias S, et al. Examining fentanyl and its analogues in the unregulated drug supply of British Columbia, Canada using drug checking technologies. Drug Alcohol Rev. 2023;42(3):538-543. doi:10.1111/dar.13580.
doi: 10.1111/dar.13580
Measham F. City checking: piloting the UK’s first community-based drug safety testing (drug checking) service in 2 city centres. Br J Clin Pharmacol. 2020;86(3):420-428. doi:10.1111/bcp.14231.
doi: 10.1111/bcp.14231
Barratt MJ, Kowalski M, Maier LJ, Ritter A. Global review of drug checking services operating in 2017. Drug Policy Modelling Program Bulletin. 2018;24:1-23.
Ondocsin J, Ciccarone D, Moran L, et al. Insights from drug checking programs: practicing bootstrap public health whilst tailoring to local drug user needs. Int J Environ Res Public Health. 2023;20(11):5999. doi:10.3390/ijerph20115999.
doi: 10.3390/ijerph20115999
Optics B. Infrared, Near Infrared and Raman Spectroscopy. https://www.bruker.com/en/products-and-solutions/infrared-and-raman.html. Accessed July 22, 2024.
Wagner KD, Fiuty P, Page K, et al. Prevalence of fentanyl in methamphetamine and cocaine samples collected by community-based drug checking services. Drug Alcohol Depend. 2023;252:110985. doi:10.1016/j.drugalcdep.2023.110985.
doi: 10.1016/j.drugalcdep.2023.110985
(MADDS) MDSDS. StreetCheck Community Drug Checking. https://www.info.streetcheck.org/. Accessed March 27, 2024.
Mohr ALA, Browne T, Mohr ALA, Nelson L, Logan BK. Phenacetin: A Toxic Adulterant Found in Illicit Street Drugs; 2021. https://www.cfsre.org/images/content/reports/public_alerts/2021.04.20.Public-Alert_Phenacetin_Final.pdf. Accessed March 27, 2024.
Use BCCoS. BCCSU Drug Checking Training. https://drugcheckingbc.ca/training/. Accessed March 27, 2024.
New York State Department of Health Issues Warning that Synthetic Cannabinoids Sold in the Mohawk Valley Contain Laboratory Confirmed Synthetic Opioids that Can Create a Deadly Cocktail. https://www.health.ny.gov/press/releases/2023/2023-09-19_synthetic_cannabinoids.htm. 2023. Accessed March 27, 2024.
Bowles JM, McDonald K, Maghsoudi N, et al. Xylazine detected in unregulated opioids and drug administration equipment in Toronto, Canada: clinical and social implications. Harm Reduct J. 2021;18(1):104. doi:10.1186/s12954-021-00546-9.
doi: 10.1186/s12954-021-00546-9
Friedman J, Montero F, Bourgois P, et al. Xylazine spreads across the US: a growing component of the increasingly synthetic and polysubstance overdose crisis. Drug Alcohol Depend. 2022;233:109380. doi:10.1016/j.drugalcdep.2022.109380.
doi: 10.1016/j.drugalcdep.2022.109380
Rammohan I, Gaines T, Scheim A, Bayoumi A, Werb D. Overdose mortality incidence and supervised consumption services in Toronto, Canada: an ecological study and spatial analysis. Lancet Public Health. 2024;9(2):e79-e87. doi:10.1016/S2468-2667(23)00300-6.
doi: 10.1016/S2468-2667(23)00300-6
McAteer JM, Mantha S Gibson BE, et al. NYC’s overdose prevention centers: data from the first year of supervised consumption services. NEJM Catal. 2024;5(5):CAT-23. doi:10.1056/CAT.23.0341.
doi: 10.1056/CAT.23.0341